Rarely are corporate fun and games aired so publically. ConMed has announced agreement with its new BFF, shareholder Coppersmith Capital Management, that sees board changes. Whether this will signal a change in strategic direction, as requested by Voce Capital Management in recent months, remains to be seen.
Surgical Implant company RTI Surgical Inc. tells us Pioneer Surgical Technology Inc., its subsidiary company, has signed an agreement with Zimmer, Inc. to supply certain products for distribution by Zimmer’s trauma business.
Endoluminal gastroesophageal reflux disease device company EndoGastric Solutions® (EGS) has reached a civil settlement with the U.S. Department of Justice over alleged misuse of procedure codes that will cost it $5.25 million.
Some outstanding sales figures from tissue sealant, hemostat, vascular and preservation services businesses underpin annual revenue growth of 7 percent.
Direct Flow Medical is a relative minnow in Transcatheter Valve World, but a new cash injection totalling $50million will help it expand and progress its plans to gain U.S. FDA approval as soon as it possibly can.
Device household name Stryker spreads its wings far beyond Orthopaedics these days, as evidenced with its newly announced acquisition of German surgical equipment maker Berchtold Holding, AG for an enterprise value of $172 million.
Some solid revenue growth for Medtronic, compared with the same quarter a year ago, were somewhat spoiled by a $200 million write down following the poor outcome from its much vaunted Symplicity HTN-3 Study.
Sorin’s financials for 2013 look pretty punchy and despite a few product-lifecycle challenges appear to indicate that the financial impact of the recent earthquake experienced at one of the company’s facilities are well behind it.
While Thoratec’s numbers landed within their guidance figures, we somehow expected to see more from a company that purports to be changing the face of the heart-assist device world. The mood music suggests they’re readying themselves for acceleration beyond 2014 though.